ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978

Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers

April 27, 2007

In Brief: Holleb Named Memorial Distinguished Alumnus; Hankey Appointed DCPC Statistics Branch Chief

September 1, 1989

An Earmark In The Making? NCI Urged to Boost Gastric Cancer Funding

December 17, 2013

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007